05/16/2024 3:27 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:41 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:41 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:44 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 3:05 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 4:26 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:42 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
|
04/29/2024 3:43 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form DEFA14A | |
04/29/2024 3:45 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form ARS | |
04/24/2024 3:06 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 2:18 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 4:26 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form PRE 14A | |
04/16/2024 4:45 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 3:11 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) SOUTHWELL DAVID P (Reporting) SOUTHWELL DAVID P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 7:39 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) White Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 2:11 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) White Mark Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024 8:47 AM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/03/2024 5:02 PM | Ondrey Aaron (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 5:07 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Schwartz Jonathan David (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/29/2024 4:17 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 7:54 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 7:58 PM | Makker Gotham (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 10:39 AM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:54 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:48 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 2:54 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 1:59 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:37 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 7:54 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) White Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:28 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Shah Gaurav (Reporting)
| Form 144/A | |
02/16/2024 3:31 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:37 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:22 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:26 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 9:17 AM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
01/23/2024 3:22 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:05 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The ONE AI Stock to own now. (It’s not Nvidia.) (Ad) Don’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. |
01/22/2024 2:16 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 10:43 AM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/12/2023 7:51 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Woods Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:42 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Woods Keith (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/16/2023 6:24 PM | Makker Gotham (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:58 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:09 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:17 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 2:21 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 2:21 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 2:28 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023 3:40 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 8:38 AM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/20/2023 5:37 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4/A | |
10/20/2023 2:19 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 8:02 PM | Makker Gotham (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:05 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 3:09 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
09/19/2023 3:15 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
09/19/2023 3:15 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) RTW INVESTMENTS, LP (Reporting) WONG RODERICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 4:16 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
09/12/2023 8:53 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2023 4:20 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
09/12/2023 3:53 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/30/2023 3:15 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) RTW INVESTMENTS, LP (Reporting) WONG RODERICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/17/2023 2:44 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 2:35 PM | Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023 2:35 PM | Patel Kinnari (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 3:17 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 4:21 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2023 3:05 PM | Militello John (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/20/2023 2:35 PM | Militello John (Reporting) Rocket Pharmaceuticals (Subject) ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2023 6:47 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:47 PM | Bjork Elisabeth (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:47 PM | GRANADILLO PEDRO P (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:47 PM | BOESS CARSTEN (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:47 PM | Makker Gotham (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:47 PM | Malik Fady Ibraham (Reporting) Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:48 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) WONG RODERICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:48 PM | Rocket Pharmaceuticals (Issuer) ROCKET PHARMACEUTICALS, INC. (Issuer) Yalamanchi Naveen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:27 PM | Rocket Pharmaceuticals (Filer) ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |